Health Checkup, Medical Treatment & Elective Surgeries
MedEx connects you to JCI accredited world-class hospitals with outstanding certifications
Click here to login
Please select date*
Name*
Email*
Contact Number
No. of Attendee(s)*
1
Pay with Stripe if you are paying with a local or international card, or Select alternative payment methods
Top Searches :
Click here to login
Please select date and time*
Name*
Email*
Contact Number
No. of Attendee(s)*
1
Pay with Stripe if you are paying with a local or international card, or Select alternative payment methods
The Malignancy Panel (FEMALE) offered by MedEx Neo Clinic is a comprehensive set of tests specifically designed to screen for and detect potential malignancies in females.
The Malignancy Panel (FEMALE) offered by MedEx Neo Clinic is a comprehensive set of tests specifically designed to screen for and detect potential malignancies in females. This panel includes a range of tumor markers that can help identify certain types of cancers and monitor their progression.
The panel includes the following tests:
Alpha Fetoprotein (AFP): This test measures the levels of AFP, a tumor marker associated with certain types of cancers, including liver cancer and certain ovarian cancers. Elevated levels of AFP may indicate the presence of these malignancies.
Beta HCG: This test measures the levels of beta human chorionic gonadotropin (HCG), a hormone produced by certain types of cancer cells, including gestational trophoblastic tumors and ovarian germ cell tumors. Elevated levels of beta HCG can be indicative of these malignancies.
CA 125: This test measures the levels of CA 125, a tumor marker commonly associated with ovarian cancer. Elevated CA 125 levels can be an indication of ovarian cancer or other gynecological malignancies.
CA 15.3: This test measures the levels of CA 15.3, a tumor marker associated with breast cancer. Monitoring CA 15.3 levels can help detect or monitor the progression of breast cancer.
CA 19.9: This test measures the levels of carbohydrate antigen 19.9 (CA 19.9), which is associated with gastrointestinal cancers, particularly pancreatic cancer. Monitoring CA 19.9 levels can help detect or monitor the progression of these malignancies.
CEA (Carcinoembryonic Antigen): This test measures the levels of CEA, a tumor marker associated with several types of cancers, including colorectal cancer and some types of breast and lung cancers. Elevated CEA levels may indicate the presence of these malignancies.
The Malignancy Panel (FEMALE) provided by MedEx Neo Clinic aims to screen for and detect potential malignancies in females by measuring specific tumor markers associated with various types of cancers. It assists in early detection, monitoring, and providing appropriate guidance for further evaluation and management. The exact pricing for the panel can be obtained directly from MedEx Neo Clinic as it may vary based on location and specific offerings.
Complete health check-up program from leading hospitals and clinics Book now at Medex